During the past decade, Fibromyalgia Association (AGRAFIM) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fibromyalgia Association (AGRAFIM)" #1 collaborator was "Universidad de Granada" with 2 trials as a collaborator and "Andaluz Health Service" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Fibromyalgia Association (AGRAFIM)" are "Temporomandibular Joint Dysfunction Syndrome" (2 trials). Many other conditions were trialed in "Fibromyalgia Association (AGRAFIM)" in a lesser frequency.

Most popular intervention types in "Fibromyalgia Association (AGRAFIM)" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Deontology Therapy" (1 trials), "Multidisciplinary therapy" (1 trials), "Physiotherapy Protocol" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fibromyalgia Association (AGRAFIM)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fibromyalgia Association (AGRAFIM)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fibromyalgia Association (AGRAFIM), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fibromyalgia Association (AGRAFIM), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".